Crossmark

Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin

Crossref DOI link: https://doi.org/10.1007/s12032-017-1058-3

Published Online: 2017-11-22

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Soyama, Hiroaki https://orcid.org/0000-0003-0841-7743
Miyamoto, Morikazu https://orcid.org/0000-0003-4763-0926
Takano, Masashi https://orcid.org/0000-0001-6916-9398
Aoyama, Tadashi https://orcid.org/0000-0002-5092-9729
Matsuura, Hiroko https://orcid.org/0000-0002-1825-6245
Sakamoto, Takahiro https://orcid.org/0000-0003-3107-5016
Takasaki, Kazuki https://orcid.org/0000-0001-6671-1858
Kuwahara, Mika https://orcid.org/0000-0003-1125-114X
Kato, Kento https://orcid.org/0000-0003-3815-0314
Yoshikawa, Tomoyuki https://orcid.org/0000-0002-3612-8490
Iwahashi, Hideki https://orcid.org/0000-0002-0139-2283
Tsuda, Hitoshi https://orcid.org/0000-0003-3457-4224
Furuya, Kenichi https://orcid.org/0000-0002-1039-6235
License Information

License valid from 2017-11-22

Document is current

Any future updates will be listed below